Pharmaceutical

Ambrilia a annoncé ce jour qu'elle envisageait un projet pouvant conduire à une réduction significative de ses activités en France. Selon l'évolution du désengagement, la société pourrait regrouper l'ensemble de ses activités en son siège socia

Ambrilia today announced that it intends to initiate a plan aiming to significantly reduce its activities in France. As the divestment strategy is progressing, the Company might concentrate all of its activities in its headquarters in Montreal and thus,

Advanced Proteome Therapeutics Corporation has announced today the resignations of two Board members, Robert Bender and Russell E. Phares, effective October 11.

Presentation to Highlight Mechanism by which L-DOS47 Targets the Cellular Microenvironment to Debilitate and Destroy Lung Adenocarcinoma Cells

American HealthChoice, Inc. , http://www.americanhealthchoice.com, a medical services company with medical clinics inTexas andTennessee, is pleased to announce the first sales of the U.S. FDA approved OmniBody Scan, an infrared thermal imaging camera tha

Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will attend the 2008 Radiological Society ofNorth America Conference inChicago, Illinois at the McCormick Place f

Advanced Proteome Therapeutics Corporation has announced today the resignations of two Board members, Robert Bender and Russell E. Phares, effective October 11.

Ambrilia today announced that it intends to initiate a plan aiming to significantly reduce its activities in France. As the divestment strategy is progressing, the Company might concentrate all of its activities in its headquarters in Montreal and thus,